We didn’t just track DX headlines in 2025 — we traveled to get the context behind them. Here’s what stood up to reality.
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Robocalls often aim to make money from you, either through scams or questionable business pitches. A common scam involves callers posing as a benefits company to get your Medicare number. Scammers may ...
CMS has unveiled the “Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence,” or Elevate, model, a voluntary initiative that will fund up to 30 chronic ...
A 100% service-connected disabled veteran receiving benefits from the Department of Veterans Affairs said he pays nothing for his medical care, dental, vision or prescriptions. So when he got his ...
Every senior on Medicare should be intimately familiar with IRMAA — the initials that stand for Income Related Monthly Adjustment Amount. It’s the amount by which your Medicare Part B and Part D ...
Every year, millions of Americans navigate the complex world of Medicare enrollment, and every year, countless people make preventable mistakes that cost them money or leave them with inadequate ...
CMS proposes Medicare coverage for legal CBD products, a move welcomed by patient advocates but complicated by looming federal hemp restrictions. A key federal health agency revealed last week that it ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...
The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...
Individuals covered under Medicare can expect significant savings on the 15 drugs that were selected earlier this year for drug price negotiations under the Inflation Reduction Act starting in 2027.